BLOOMBERG Street Smart With Trish Regan And Adam Johnson April 2, 2014
Moment hasnt come. Twowe can rethink the past this future and why he did not take the ceo at microsoft, samuel paul masato. We are looking at a huge increase in shares of mankind, a pharmaceutical maker. It doesnt actually have any drugs on the market. The first could be its in held insulin diabetes treatment. It will get fda approval but it has an important step and shares are just about doubling in one day. Another big game today is for intuitive surgical. Shares were up even more yesterday when he did get fda approval for its da vinci surgical robot. Upgraded shares of intuitive. Privateduc...